+147.0%
MRNA vs FTI
+187.1%
-40.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FTI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -4.2% | +2.1% | -2.0% |
| 7D | -12.7% | -11.3% | -1.4% | -12.4% |
| 30D | -20.7% | -16.1% | -4.6% | -20.4% |
| 3M | +46.3% | -24.3% | +70.6% | +47.2% |
| 6M | +305.2% | -18.6% | +323.9% | +302.7% |
| YTD | +561.2% | +32.1% | +529.1% | +485.7% |
| 1Y | +772.1% | +35.4% | +736.7% | +668.4% |
| 3Y | +147.0% | +184.7% | -37.8% | +71.3% |
| All | +147.0% | +187.1% | -40.1% | +71.3% |
Cumulative growth
Daily Returns
Daily percentage return beside FTI.
Daily Out/Under-Performance
Portfolio return minus FTI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FTI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FTI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling